Finally, our results suggest that RISP is a potential therapeutic target for interventions aimed at reducing abnormal cell proliferation and migration associated with pulmonary vascular remodeling and pulmonary hypertension. The gene discussed is UQCRFS1; the disease is pulmonary arterial hypertension.